{"id":5488,"date":"2012-11-18T21:42:53","date_gmt":"2012-11-18T21:42:53","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/bellaire-dermatology-announces-it-is-recruiting-patients-for-psoriasis-and-acne-cyst-clinical-trials\/"},"modified":"2012-11-18T21:42:53","modified_gmt":"2012-11-18T21:42:53","slug":"bellaire-dermatology-announces-it-is-recruiting-patients-for-psoriasis-and-acne-cyst-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/bellaire-dermatology-announces-it-is-recruiting-patients-for-psoriasis-and-acne-cyst-clinical-trials\/","title":{"rendered":"Bellaire Dermatology Announces it is Recruiting Patients for Psoriasis and Acne Cyst Clinical Trials"},"content":{"rendered":"<p><p>    Bellaire    Dermatology is recruiting patients for two clinical trials as    part of their ongoing efforts to offer innovative and effective    dermatology    treatments. The first trial is for a drug called    AMAGINE-3, which treats severe psoriasis plaques. The second study is    the use of Acleara for treaing acne cysts. Patients interested    in this study should contact the office for additional    information.  <\/p>\n<p>    Bellaire,    TX (PRWEB) November 14, 2012  <\/p>\n<p>    The psoriasis study is currently in phase 3 of the clinical    trial for the AMAGINE-3 investigational psoriasis medication    known as brodalumab. Brodalumab (new IL-17 blocker) is a type    of protein that blocks the interaction of other proteins in the    body that can cause inflammation and symptoms related to    psoriasis. Although there are several types of psoriasis,    approximately 80 percent of patients have plaque psoriasis,    which can cause painful and itchy red, scaly patches to appear    on the skin. Bellaire Dermatology is recruiting patients from    18 to 75 years of age that have been diagnosed with moderate to    severe plaque psoriasis for at least six months prior to this    trial.  <\/p>\n<p>    \"Bellaire Dermatology is excited to assist with conducting this    dermatology clinical research trial here at our research center    in Houston,\" says Dr. Craig Teller. \"This procedure may be able    to help patients who are unable to achieve therapeutic goals    with the existing treatment options for psoriasis.\"  <\/p>\n<p>    The second trial currently available at Bellaire Dermatology is    for Acleara. This system has already been approved by the FDA    to treat mild inflammation for acne using light and vacuum    technology. It both removes sebaceous material that causes acne    as well as light to destroy the bacteria responsible for acne.    Bellaire Dermatology is conducting a clinical trial to examine    the effects of the Acleara system on acne cysts. Interested    patients should call (713) 661-4383 or email    clinicaltrials(at)bda-derm(dot)com to learn more.  <\/p>\n<p>    Bellaire Dermatology is a leading cosmetic, surgical and    medical dermatology office in Houston, Texas. The practice    specializes in dermatology services including acne treatment,    Botox, Juvederm, injectable    fillers, cosmetic fillers, vein treatments, CoolSculpting, laser    resurfacing, and Mohs Surgery. Bellaire    Dermatology offers personalized treatment plans and the most    current and effective dermatological therapies available.  <\/p>\n<p>    Ariane Blocher    Bellaire Dermatology Associates    (713) 661-4383    Email Information  <\/p>\n<\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" href=\"http:\/\/news.yahoo.com\/bellaire-dermatology-announces-recruiting-patients-psoriasis-acne-cyst-140225084.html;_ylt=A2KJ3CVXVqlQm24AnzD_wgt.\" title=\"Bellaire Dermatology Announces it is Recruiting Patients for Psoriasis and Acne Cyst Clinical Trials\">Bellaire Dermatology Announces it is Recruiting Patients for Psoriasis and Acne Cyst Clinical Trials<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Bellaire Dermatology is recruiting patients for two clinical trials as part of their ongoing efforts to offer innovative and effective dermatology treatments. The first trial is for a drug called AMAGINE-3, which treats severe psoriasis plaques <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/bellaire-dermatology-announces-it-is-recruiting-patients-for-psoriasis-and-acne-cyst-clinical-trials\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-5488","post","type-post","status-publish","format-standard","hentry","category-psoriasis"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/5488"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=5488"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/5488\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=5488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=5488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=5488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}